Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Axial Spondyloarthritis (AxSpA)
85%
Ankylosing Spondylitis
73%
Primary Sjögren's Syndrome
57%
Primary Sjgren Syndrome
56%
Disease Activity
48%
Daily Clinical Practice
34%
European League against Rheumatism (EULAR)
34%
Disease Activity Score
31%
Short Questionnaire
26%
Ultrasound
24%
Salivary Gland Ultrasonography
23%
Tumor Necrosis Factor-α
23%
Block Therapy
22%
TNF Inhibitors
22%
Parotid Gland
21%
Sjögren's Syndrome
21%
Salivary Gland
20%
Radiographic Progression
19%
Health-enhancing Physical Activity
19%
Abatacept
19%
Dutch
18%
Major Salivary Gland
17%
Giant Cell Arteritis
17%
Physical Activity
17%
Bone Mineral Density
17%
Minor Salivary Gland Biopsy
17%
Cross-cultural Adaptation
16%
Sjgren's Syndrome
16%
Groningen
15%
Clinical Trials
15%
Large Cohort
15%
Vertebral Fracture
14%
Quality of Life
13%
Daily Physical Activity
13%
OMERACT
13%
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
13%
Systemic Disease
13%
Central Sensitization
12%
Rheumatoid Arthritis
12%
Tumor Necrosis Factor Inhibitor (TNFi)
12%
B Cells
12%
American College of Rheumatology
11%
ESSDAI
11%
Bone Turnover Markers
11%
Interobserver Reliability
11%
Intraclass Correlation Coefficient
11%
Healthy Controls
11%
Sicca
11%
Lupus Nephritis
11%
Parotid
11%
Medicine and Dentistry
Diseases
100%
Ankylosing Spondylitis
80%
Spondylarthritis
73%
Sjoegren Syndrome
56%
Disease Activity
54%
Salivary Gland
48%
Tumor Necrosis Factor
37%
Physical Activity
29%
Quality of Life
29%
Echography
26%
Parotid Gland
23%
Biopsy Technique
22%
TNF Inhibitor
22%
Bone Turnover
21%
Rheumatology
17%
Rheumatic Disease
15%
Bone Density
14%
Lupus Nephritis
14%
Giant-Cell Arteritis
13%
Sensitization
13%
Clinical Trial
12%
Abatacept
12%
Spine Fracture
12%
Cohort Studies
12%
Ankylosing Spondylitis Disease Activity Score
11%
Patient-Reported Outcome
11%
Outpatient
10%
Disease Duration
10%
Inflammation
10%
Health Status
10%
Submandibular Gland
10%
BASDAI
9%
Positron Emission Tomography-Computed Tomography
9%
Area under the Curve
9%
Salivary Gland Biopsy
9%
Body Mass Index
9%
Cross Sectional Study
9%
Prevalence
9%
Color Doppler Flowmetry
9%
Rheumatoid Arthritis
9%
Inflammatory Arthritis
9%
Disease Activity Score
8%
Rituximab
8%
Systemic Lupus Erythematosus
8%
B Lymphocyte
7%
Randomized Controlled Trial
7%
Patient Characteristics
7%
Facet Joint
7%
Lacrimal Gland
7%
Systemic Disease
7%